CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new non-viral vectors for gene therapy aimed at treating ocular neovascularization, a leading cause of blindness. By combining the inhibition of angiogenic factors with the expression of anti-angiogenic factors, the project seeks to create effective therapies that can restore vision a…
Ocular neovascularization (NV) is the pathological feature common to Retinopathy of Prematurity, Diabetic Retinopathy, and Age-related Macular Degeneration.
Collectively, these diseases are the leading cause of blindness in developed countries, and even more relevant due to the increased life expectancy.
Current therapies can delay the progression of the disease, but do not restore the vision already lost.
Therefore, there is a need for new, more efficient anti-angiogenic therapies.
Gene therapy…
UNIVERSIDADE DO ALGARVE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
